Kurt Gebauer

7PUBLICATIONS
36CO-AUTHORS
AllergyHaematological tumoursTransport properties and non-equilibrium processesClinical pharmacology and therapeuticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 21, 2026
Safety and pharmacokinetics of anumigilimab for hidradenitis suppurativa or palmoplantar pustulosis: A phase 1b study.

|Jan 09, 2026
Retrospective Analysis of the Recurrence of Atypical Fibroxanthoma When Treated With Curettage and Cautery at a Single Centre.

Nehel Binte-Mehdi Syed, Kurt Gebauer

|Dec 29, 2025
Delayed Bullous Drug Eruption Induced by Elexacaftor/Tezacaftor/Ivacaftor.

Tatiana Ninkov, Megan Yap, Nima Mesbah Ardakani

|Aug 05, 2025
Guidelines for Phototherapy and PUVA Service Delivery in Australia: Minimum Standards and Quality Assurance Framework.

Stephanie Tan, Kurt GeBauer

|May 14, 2025
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology Group.

Marius Rademaker, Peter Foley, Katherine Armour

|Jul 28, 2023
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.

Peter Foley, Kurt Gebauer, John Sullivan

Pageof 2